Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Early research (Phase 1)Study completedNCT03568539
What this trial is testing

IBI308 in Subjects With Advanced/Metastatic Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Malignancies
Innovent Biologics (Suzhou) Co. Ltd. 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07739966
What this trial is testing

DS-3939a in Participants With Solid Tumors

Who this might be right for
Solid TumorLocally Advanced Non-Small Cell Lung CancerMetastatic Non-Small Cell Lung Cancer
Daiichi Sankyo 400
Testing effectiveness (Phase 2)Looking for participantsNCT06922357
What this trial is testing

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Shandong Suncadia Medicine Co., Ltd. 120
Early research (Phase 1)Ended earlyNCT02358200
What this trial is testing

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

Who this might be right for
Triple Negative Metastatic Breast CancerBRCA-mutated Solid Tumor
Pamela Munster 23
Not applicableStudy completedNCT05236257
What this trial is testing

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

Who this might be right for
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene FusionInfantile Fibrosarcoma
Bayer 93
Early research (Phase 1)Looking for participantsNCT07279428
What this trial is testing

BL-M24D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Active Not RecruitingNCT04294628
What this trial is testing

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 62
Early research (Phase 1)Looking for participantsNCT06771219
What this trial is testing

SLV-154 Treatment of Advanced Cancers

Who this might be right for
Advanced CancerAdvanced Solid TumorMetastatic Cancer
Solve Therapeutics 250
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Testing effectiveness (Phase 2)Ended earlyNCT03729596
What this trial is testing

MGC018 With or Without MGA012 in Advanced Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more
MacroGenics 143
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Early research (Phase 1)Study completedNCT04403308
What this trial is testing

ONO-7913 Phase I Study (ONO-7913)

Who this might be right for
Solid Tumor
Ono Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Ended earlyNCT06198426
What this trial is testing

IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 5
Early research (Phase 1)Study completedNCT01571024
What this trial is testing

BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Colorectal CancerMetastatic Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT05735080
What this trial is testing

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Who this might be right for
Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more
Incyclix Bio 150
Early research (Phase 1)Looking for participantsNCT06545942
What this trial is testing

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more
MOMA Therapeutics 220
Early research (Phase 1)Ended earlyNCT02122146
What this trial is testing

PF-06664178 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 31
Early research (Phase 1)Study completedNCT02514603
What this trial is testing

Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers

Who this might be right for
Neoplasm
Eli Lilly and Company 12
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Next Page